Stockscreener 앱 받기
338.98
2.03%
6.73
Elevance Health Inc 주식(ELV)의 최신 뉴스
Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight - GuruFocus
Elevance Health, Inc. SEC 10-K Report - TradingView
Elevance Health, Inc. (ELV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Elevance Fights Nurses' '11th Hour' Class Expansion - Law360
Molina retreats from Medicare Advantage after forecast miss - Modern Healthcare News
Johnson Fistel, PLLP Begins Investigation on Behalf of - GlobeNewswire
Elevance Health seeks more than $1M in breach of contract lawsuit against former execs - Inside INdiana Business
Insurance companies are fining hospitals for out-of-network care. A new bill aims to stop it - WFYI
Elevance Health sues former executives for more than $1M - Indianapolis Business Journal
Elevance Health seeks more than $1M in breach of contract lawsuit against former executives - The Indiana Lawyer
Jones Financial Companies Lllp Boosts Holdings in Elevance Health, Inc. $ELV - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elevance Health, Inc. (ELV) and Encourages Stockholders to Learn More About the Investigation - accessnewswire.com
5 Revealing Analyst Questions From Elevance Health's Q4 Earnings Call - Finviz
5 Revealing Analyst Questions From Elevance Health’s Q4 Earnings Call - Yahoo Finance
This Week's Healthcare Earnings: Novo, Elevance And More - Law360
Agree To Buy Elevance Health At $165, Earn 3% Using Options - Nasdaq
Guggenheim Adjusts Elevance Health Price Target to $414 From $398, Maintains Buy Rating - marketscreener.com
Elevance Health (NYSE:ELV) Cut to "Sector Perform" at Royal Bank Of Canada - MarketBeat
RBC Downgrades Elevance Health to Sector Perform From Outperform, Cuts Price Target to $358 From $392 - marketscreener.com
Principal Financial Group Inc. Has $83.83 Million Holdings in Elevance Health, Inc. $ELV - MarketBeat
Earnings call transcript: Elevance Health Q4 2025 beats EPS forecast - Investing.com
Earnings call transcript: Elevance Health Q4 2025 beats EPS forecast By Investing.com - Investing.com India
Elevance Health, Inc. (ELV) Stock Analysis: Understanding The 12.82% Potential Upside - DirectorsTalk Interviews
Elevance Health: It Has Been Painful, But This Too Shall Pass (ELV) - Seeking Alpha
JP Morgan Raises Price Target on Elevance Health (ELV) | ELV Sto - GuruFocus
Elevance Health, Inc.'s (NYSE:ELV) Stock Has Fared Decently: Is the Market Following Strong Financials? - 富途牛牛
Is the Options Market Predicting a Spike in Elevance Health Stock? - TradingView
JPMorgan Chase & Co. Boosts Elevance Health (NYSE:ELV) Price Target to $397.00 - MarketBeat
Elevance Health (NYSE:ELV) Price Target Cut to $390.00 by Analysts at Truist Financial - MarketBeat
Elevance Health Shares Face Pressure Amid Cautious 2026 Guidance - AD HOC NEWS
Veritas Asset Management LLP Has $291.75 Million Stake in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Position Lifted by Mawer Investment Management Ltd. - MarketBeat
Elevance Health, Inc. $ELV Stock Holdings Lowered by Yacktman Asset Management LP - MarketBeat
National Pension Service Grows Stock Position in Elevance Health, Inc. $ELV - MarketBeat
AlphaQuest LLC Purchases New Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health targets at least $25.50 adjusted EPS for 2026 as company signals margin recovery and portfolio repositioning - MSN
Jefferies Financial Group Has Lowered Expectations for Elevance Health (NYSE:ELV) Stock Price - MarketBeat
Sanford C. Bernstein Has Lowered Expectations for Elevance Health (NYSE:ELV) Stock Price - MarketBeat
Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating - Finviz
Barclays adjusts Elevance Health (ELV) PT to $393 while maintaining overweight rating - MSN
Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.72 - Yahoo Finance
Elevance Health (NYSE:ELV) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Elevance Health Earnings Call Flags Reset Before Rebound - TipRanks
Elevance Health Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Elevance Health (ELV): Wells Fargo Lowers Price Target, Maintains Overweight Rating | ELV Stock News - GuruFocus
Elevance Health (NYSE:ELV) Price Target Raised to $357.00 - MarketBeat
Wells Fargo Adjusts Price Target on Elevance Health to $391 From $424, Maintains Overweight Rating - marketscreener.com
Jefferies Adjusts Price Target on Elevance Health to $395 From $401, Maintains Buy Rating - marketscreener.com
Y Intercept Hong Kong Ltd Cuts Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Shares Bought by New York State Common Retirement Fund - MarketBeat
Truist Financial Corp Reduces Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health Resets 2026 Outlook As Investors Weigh Long Term Payoff - Yahoo Finance
Health Insurance Stock Could Rebound Off Historically Bullish Signal - Finviz
Analyst Expectations For Elevance Health's Future - Benzinga
Elevance Health posts Q4 gains - Insurance Business
Elevance Health latest health insurer to lower 2026 revenue expectations - Healthcare Finance News
Street View: Elevance Health's forecast achievable, sees runway for improvement - TradingView
Deutsche Bank Adjusts Price Target on Elevance Health to $332 From $320, Maintains Hold Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Elevance Health to $350 From $331, Maintains Neutral Rating - marketscreener.com
Deutsche Bank Lifts Price Target on Elevance Health to $332 From $320, Keeps Hold Rating - marketscreener.com
Elevance Health Inc. (NYSE:ELV) Q4 2025 Earnings Call Transcript - Insider Monkey
ELV Q4 Deep Dive: Margin Pressures and Membership Shifts Shape 2026 Outlook - Finviz
Bank of New York Mellon Corp Boosts Holdings in Elevance Health, Inc. $ELV - MarketBeat
Truist Financial Reaffirms Their Buy Rating on Elevance Health (ELV) - The Globe and Mail
Elevance Health, Inc. (NYSE:ELV) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Elevance Health stock rebounds nearly 6% after earnings — here’s what matters before Thursday’s trade - TechStock²
Elevance Health Inc (ELV) Q4 2025 Earnings Call Highlights: Stro - GuruFocus
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums - sharewise.com
Elevance Health, Inc. (NYSE:ELV) Plans Dividend Increase$1.72 Per Share - MarketBeat
Elevance Health Inc (ELV) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid ... - Yahoo Finance
Elevance Health sets 'prudent' 2026 guidance as it navigates ongoing cost, utilization pressures - Fierce Healthcare
2.64%
3.66%
자본화:
|
볼륨(24시간):